Phase IIA Open Label Study to Evaluate Efficacy and Safety of BL-8040 Followed by (hATG), Cyclosporine and Methyprednisolone in Adult Subjects With Aplastic Anemia or Hypoplastic Myelodysplastic Syndrome
Conditions: Aplastic Anemia; Hypoplastic Myelodysplastic Syndrome
Interventions: Drug: BL-8040; Drug: horse anti-thymocyte globulin (hATG); Drug: Methylprednisolone; Drug: Cyclosporine
Sponsor: BioLineRx, Ltd.
Recruiting - verified June 2016
Interventions: Drug: BL-8040; Drug: horse anti-thymocyte globulin (hATG); Drug: Methylprednisolone; Drug: Cyclosporine
Sponsor: BioLineRx, Ltd.
Recruiting - verified June 2016